Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
about
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.Androgen Receptor Signaling in Salivary Gland Cancer.Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management.A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.Developing Androgen Receptor Targeting for Salivary Gland Cancers.Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression.Acquisition of resistance to androgen deprivation therapy in salivary duct carcinoma: A case report
P2860
Q34532980-3A98DFEA-6BC8-448F-8F04-E9A9933345C9Q36874710-6BB131EC-5EB8-472F-8A46-3334886B888EQ37676074-F5722B40-5E07-4749-86AB-12C0FC9AB941Q41708696-1F33B36C-17C4-4169-B8F5-0263D598A694Q45996599-F22B2550-77C8-4C61-84A2-5AF47180E837Q47259493-21052FFC-E38A-44B0-8DAB-B3E3C5734862Q47859326-52FDF0B8-0872-4132-A849-49A69D94B8B8Q48236697-252A4D4A-D785-42C5-9DFB-4D339DF3A938Q50049535-72DE1583-CB50-45A3-8779-F994EE6CD670Q50132910-E3E0C77B-6D0B-488B-86E0-2794E45A9A79Q55452685-202AF41B-E3A4-4545-BEEE-7EAEB28F54C3Q55465923-B3FD83E3-B03C-459B-AE74-A1C4E4F8343FQ58718493-FE83BC4D-07C4-469A-BA65-C1E73D1087A9
P2860
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinical activity of androgen ...... sitive salivary gland cancers.
@en
Clinical activity of androgen ...... sitive salivary gland cancers.
@nl
type
label
Clinical activity of androgen ...... sitive salivary gland cancers.
@en
Clinical activity of androgen ...... sitive salivary gland cancers.
@nl
prefLabel
Clinical activity of androgen ...... sitive salivary gland cancers.
@en
Clinical activity of androgen ...... sitive salivary gland cancers.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinical activity of androgen ...... sitive salivary gland cancers.
@en
P2093
Barbara Cortelazzi
Carlo Fallai
Silvana Pilotti
P2860
P304
P356
10.1002/HED.23940
P50
P577
2015-06-25T00:00:00Z